Delivering Pharmaceutical Innovations Domestically and Globally

Toward Realizing the JPMA's Vision for 2035Our activities are centered on the three pillars of Innovation, Access, and Trust.

Toward Realizing the JPMA's Vision for 2035

Updates

SNS News

April 14, 2026

The North America Group of the European and American Subcommittees of the #JPMA #International Affairs Committee held a study session with Mr. Lu (Greenberg Traurig), an attorney practicing in the United States, as a lecturer.

He spoke about policy and regulatory trends surrounding the pharmaceutical industry in the U.S., and opinions were exchanged.

April 09, 2026

News Release

The Japan Council on the Proper Use of Drugs, the Japan Pharmaceutical Manufacturers Association, and the #JPMA have collaborated to produce an educational material for the general public on how to identify medical and health information, "Don't believe everything you read! which is an educational material for the general public on how to identify medical and health information, and released it on each organization's website on April 9.

For more information, click here 👇.
https://www.jpma.or.jp/news_room/release/2026/260409.html

Apr 08, 2026.

Drug discovery karuta" created by female junior high and high school students is now available✨.

DL is here 👇.
https://www.jpma.or.jp/information/industrial_policy/report/260402.html

The girls expressed the realities of drug discovery such as AI, iPS cells, drug-resistant bacteria, drug loss, etc. in their own words!
#GirlsMeetSTEM #STEM #Science Museum #Alchemy Notebook

Apr 08, 2026.

On April 3, the Quality culture PJ of the #JPMA #Quality & Technology Committee and the Toyama Pharmaceutical Association held the third meeting to exchange opinions following 2025.

Lively discussions were held on quality culture. The content of the exchange of opinions will be shared at the JPMA GMP Case Study Group and utilized in quality assurance efforts in the future!

Apr 03, 2026.

On March 28, #JPMA Chairman Miyabashira took the podium at the Diversity Promotion Symposium of the Pharmaceutical Society of Japan! He spoke about human resource development efforts in the pharmaceutical industry and the importance of diversity in creating innovation!

Apr 02, 2026.

# JPMA held a career awareness seminar for junior high and high school students at the annual meeting of the Pharmaceutical Society of Japan last weekend.

How drugs are created and delivered to patients 💊 Through the story of how drugs are created and delivered to patients, the seminar introduces the appeal and satisfaction of working in pharmacy and drug discovery!

We hope this seminar will be an opportunity for the young people who will be responsible for the next generation of pharmacy and drug discovery to chart their own future 🌱.

Apr 02, 2026.

# JPMA also co-sponsored the "63rd Advertising Conference Awards for Junior High and High School Students".
Among the many entries, more than 100 people from the JPMA were involved in the judging process and selected 6 catchphrases 🏅.

Congratulations to all the winners 🎉.
The selected works will be used in JPMA's future PR activities!

To read about the judging process and interviews with the winners, please visit 👇.
https://www.jpma.or.jp/information/public_affairs/pr/2025/index.html

Apr 01, 2026.

JPMA website Top page renewed!

#JPMA ' s Vision for 2035 (Innovation, Access, and Trust), the three pillars of JPMA's Vision for 2035, has been reorganized and visualized in a new structure 👇.

https://www.jpma.or.jp/

Following the recent introduction of automatic translation (English), we will continue to strengthen our ability to communicate domestically and internationally✨.

Mar 31, 2026.

Policy Research Institute #Position Paper No. 14 is now available📊.
The theme of this issue is here👇.

✅Japanese Patient-Reported Outcome (PRO) Compendium - Facts about Phase III Clinical Trials
https://www.jpma.or.jp/opir/positionpaper/pp_014/article_014.html

Please take a look!
#Policy Research Institute #Patient-Reported Outcome #PRO

March 27, 2026

Today is #Sakura Day🌸

The season to enjoy beautiful cherry blossoms is here again this year✨.
Here are some pictures of cherry blossoms taken in Nihonbashi-Honcho, where #JPMA 's office is located 📸.

I hope you have a peaceful and relaxing spring 😊.

Please take care of yourself today and have a wonderful day🍀.

March 27, 2026

Medical DX is becoming a theme for society as a whole to think about.

A video discussing the future of healthcare was released at #NewsPicks "Innovation for 2030"!
JPMA challenged a new approach this time, using a short drama to "feel" and a session to "think"!
Click here to watch the video 👇.
https://newspicks.com/live-movie/6646/

#Ranmaru Kishitani #Makiko Nakamuro #Aisako Tsuji #Eric Matsunaga

Mar 24, 2026.

On March 23, JPMA participated in "Girls Meet STEM" for the first time! ✨

Through drug discovery karuta, molecular model making, and roundtable discussions with female researchers, students were exposed to the world of science and medicine 🔬.
Hoping for more people to become future scientists 🌱.

#GirlsMeetSTEM #STEM

Mar 23, 2026.

Policy Research Institute #Position Paper No. 13 is now available📊.
Here is the theme of this issue 👇👇.

✅ Comparison of Drug Originators and Drug Discovery Support Environments Across Metropolitan Areas
https://www.jpma.or.jp/opir/positionpaper/pp_013/article_013.html

Please take a look!
#Policy Research Institute #Drug Discovery Ecosystem #City-area comparisons

March 19, 2026

#Only One of the Palace Pillars💬.

#JPMA Hosted first ever JPMA Town Hall! Thanks for the opportunity for dialogue. Did you enjoy the hot talk by the regular vice president & chairman of the board of directors?

Toward an organization that is resilient to change and can contribute to society

View X posts

About JPMA

Under the JPMA Board of Directors, 12 committees composed of member companies and 6 specialized organizations, including the Office of Pharmaceutical Industry Research (OPIR) which functions as a think tank, carry out a wide range of initiatives. These activities aim to establish a robust drug discovery ecosystem for the development of innovative pharmaceuticals, ensure compliance with regulatory frameworks such as the Pharmaceuticals and Medical Devices Act, and build trust with key stakeholders.

Each committee and specialized body bring together a diverse pool of talent - from young professionals to experienced experts - working across organizational boundaries. Through mutual collaboration and constructive exchange, they advance pharmaceutical innovation, promote the appropriate use of medicines, enhance transparency in distribution, foster international cooperation, and formulate policy proposals. In addition, JPMA conducts various surveys and research projects to address industry-wide challenges. By working closely with government authorities, patient advocacy groups, and other relevant organizations, JPMA supports the sound and sustainable development of the pharmaceutical industry.

For more information, click here.

JPMA's Vision

01
Innovation

Consistently produce innovations to benefit health spans and the economy

  • Pharmaceutical innovations
  • Leading-edge scientific technology
  • Pharmaceutical manufacturing technology
  • Domestic manufacturing infrastructure
  • Making Japan a science and technology powerhouse
  • Fostering highly skilled talent
  • PPI/E
  • Drug discovery that involves patients and the public
  • Co-creation
  • Drug discovery ecosystem
  • Job creation
  • Extending health spans
  • Well being
  • Pharma as a core industry
  • Economic growth
02
Access

Bring innovative new drugs to the public more quickly to enhance health security

  • A social security system that gives patients swift access to “the latest treatments” and stable access to “global-standard treatments”
  • Positive investment cycle
  • Building an attractive domestic market
  • Drug pricing that properly factors in the worth of innovation
  • Health security for Japan
03
Trust

Commit to ethical conduct and transparency to foster trust in the pharma industry

  • Sustainable Development Goal 3 (Ensure healthy lives and promote well-being for all at all ages)
  • Overcome the social challenges raised by Japan’s aging population
  • Ethical soundness, code of behavior, and transparency
  • Boost public literacy in health and medicine
  • Social significance of pharmaceuticals and the pharma industry
  • Encourage the public and younger people to enter the pharma industry
  • Climate change
  • Environmental issues
Patient and the public perspective

JPMA's Vision

Member Companies

The JPMA has 68 R&D-oriented JPMA member companies (as of April 1, 2026).

List of Member Companies

Special and Related Websites